Your browser doesn't support javascript.
loading
ECMELLA as a bridge to heart transplantation in refractory ventricular fibrillation: A case report.
Giraud, Raphaël; Assouline, Benjamin; Burri, Haran; Shah, Dipen; Meyer, Philippe; Degrauwe, Sophie; Kirsch, Matthias; Bendjelid, Karim.
Affiliation
  • Giraud R; Intensive Care Unit, Geneva University Hospitals, Geneva, Switzerland.
  • Assouline B; Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Burri H; Geneva Hemodynamic Research Group, Geneva, Switzerland.
  • Shah D; Intensive Care Unit, Geneva University Hospitals, Geneva, Switzerland.
  • Meyer P; Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Degrauwe S; Geneva Hemodynamic Research Group, Geneva, Switzerland.
  • Kirsch M; Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Bendjelid K; Department of Cardiology, Geneva University Hospitals, Geneva, Switzerland.
Front Cardiovasc Med ; 10: 1074544, 2023.
Article in En | MEDLINE | ID: mdl-36860277
ABSTRACT

Background:

Extracorporeal membrane oxygenation (ECMO) is an effective cardiorespiratory support technique in refractory cardiac arrest (CA). In patients under veno-arterial ECMO, the use of an Impella device, a microaxial pump inserted percutaneously, is a valuable strategy through a left ventricular unloading approach. ECMELLA, a combination of ECMO with Impella, seems to be a promising method to support end-organ perfusion while unloading the left ventricle. Case

summary:

The present case report describes the clinical course of a patient with ischemic and dilated cardiomyopathy who presented with refractory ventricular fibrillation (VF) leading to CA in the late postmyocardial infarction (MI) period, and who was successfully treated with ECMO and IMPELLA as a bridge to heart transplantation.

Discussion:

In the case of CA on VF refractory to conventional resuscitation maneuvers, early extracorporeal cardiopulmonary resuscitation (ECPR) associated with an Impella seems to be the best strategy. It provides organ perfusion, left ventricular unloading, and ability for neurological evaluation and VF catheter ablation before allowing heart transplantation. It is the treatment of choice in cases of end-stage ischaemic cardiomyopathy and recurrent malignant arrhythmias.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Cardiovasc Med Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Cardiovasc Med Year: 2023 Document type: Article Affiliation country:
...